Oral Steroids in Post-Facelift Patients
Oral steroids should NOT be routinely administered to post-facelift patients, as the available evidence demonstrates no significant benefit in reducing postoperative edema or ecchymosis, while exposing patients to unnecessary risks.
Evidence Against Routine Steroid Use in Facelift Surgery
The research specifically examining steroid use in facelift patients shows no clinical benefit:
A prospective, double-blind randomized study of 30 consecutive facelift patients found no significant differences in facial swelling between steroid-treated and untreated groups at any postoperative time point 1
A systematic review of facial plastic surgery procedures confirmed that the only study assessing facelift surgery identified no positive effect on edema with preoperative corticosteroid administration 2
Multiple studies examining oral postoperative steroids in facial plastic surgery (including a 60-patient double-blind trial) demonstrated no significant differences in edema or ecchymosis between steroid and placebo groups 3
A randomized study of 50 facelift patients receiving betamethasone 6 mg IM preoperatively showed no statistically significant difference in swelling at postoperative days 5 or 9 4
Limited Evidence for Other Facial Procedures
While some evidence exists for rhinoplasty showing transient benefit in the first 48 hours, this does not translate to facelift surgery:
For rhinoplasty specifically, a single perioperative dose of 10 mg dexamethasone decreased edema formation only in the first two days after surgery, with no maintained benefit thereafter 2
A comprehensive systematic review concluded that steroid use is not warranted in the postoperative period for facial plastic surgery and only reduces transient edema and ecchymosis 5
Clinical Recommendation
Do not administer oral steroids to post-facelift patients as there is no evidence of clinical benefit specific to this procedure, and short-term corticosteroid administration carries potential risks without demonstrated improvement in patient outcomes, recovery time, or satisfaction 2, 5
Important Caveats
The only scenario where perioperative steroids would be indicated in a facelift patient is if they have pre-existing adrenal insufficiency or are already receiving therapeutic glucocorticoids (prednisolone ≥5 mg daily for >1 month). In such cases, stress-dose steroid coverage would be required per established guidelines, not for edema reduction but for prevention of adrenal crisis 6